Product Information
ONFI 20 MG TABLET is a brand product labeled by Lundbeck Pharmaceuticals LLC, priced at $59.9229 per EA under NDC 67386031501. Its NADAC has been published 649 times since Mar 19, 2014.
FDA first approved this application on Oct 21, 2011. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the clobazam market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
20 mg/1
Manufacturer
Lundbeck Pharmaceuticals LLCNDC
67386031501
Classification
Brand
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
CLOBAZAMApproval Type
New Drug (NDA)
FDA Application
NDA202067FDA Approved
10/21/2011
TE Code
AB
On Market Since
12/10/2013
Pharmacological Classes
Price Statistics
The NADAC for ONFI 20 MG TABLET has been published 649 times since Mar 19, 2014, and over the history we have for it it has risen 277.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $59.9229 per EA |
|---|---|
| All-time high | $60.1682 (May 14, 2025) |
| All-time low | $15.5565 (Sep 17, 2014) |
| 52-week high | $60.0762 |
| 52-week low | $59.8697 |
| Median price | $41.8745 |
| Average price | $41.1351 |
| Largest weekly change | +19.9% (Sep 16, 2015) |
| Weeks tracked | 649 |
| Tracking since | Mar 19, 2014 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 98% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of ONFI 20 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ONFI 20 MG TABLET, manufactured by Lundbeck Pharmaceuticals LLC, is $59.9229 per EA (NDC 67386031501), effective Aug 19, 2026.
How has the price of ONFI 20 MG TABLET changed over time?
Over the history we have for it, the NADAC for ONFI 20 MG TABLET has risen 277.1%. It has been tracked across 649 weekly CMS publications since Mar 19, 2014.
What are the highest and lowest recorded NADAC prices for ONFI 20 MG TABLET?
Since Mar 19, 2014, the NADAC for ONFI 20 MG TABLET has ranged from a low of $15.5565 (Sep 17, 2014) to a high of $60.1682 (May 14, 2025), with a median of $41.8745 per EA.
Are there cheaper alternatives to ONFI 20 MG TABLET?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, CLOBAZAM 20 MG TABLET, is $0.9377 per EA — about 98% below ONFI 20 MG TABLET.
Who manufactures ONFI 20 MG TABLET?
ONFI 20 MG TABLET (NDC 67386031501) is labeled by Lundbeck Pharmaceuticals LLC, and CMS classifies it as a brand product.